Ubs Group Ag Chemo Centryx, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$22.17 - $51.8 $468,784 - $1.1 Million
21,145 Added 22.41%
115,482 $5.97 Million
Q2 2022

Aug 10, 2022
SELL
$15.36 - $27.51 $1.13 Million - $2.03 Million
-73,833 Reduced 43.9%
94,337 $2.34 Million
Q1 2022

May 16, 2022
BUY
$22.22 - $39.12 $3.48 Million - $6.13 Million
156,793 Added 1378.16%
168,170 $4.22 Million
Q4 2021

Feb 14, 2022
SELL
$18.38 - $40.5 $1.8 Million - $3.96 Million
-97,897 Reduced 89.59%
11,377 $414,000
Q3 2021

Nov 15, 2021
BUY
$13.18 - $19.83 $1.19 Million - $1.8 Million
90,544 Added 483.42%
109,274 $1.87 Million
Q2 2021

Aug 13, 2021
SELL
$9.59 - $50.88 $387,129 - $2.05 Million
-40,368 Reduced 68.31%
18,730 $251,000
Q1 2021

May 12, 2021
SELL
$49.53 - $68.4 $3.54 Million - $4.89 Million
-71,430 Reduced 54.72%
59,098 $3.03 Million
Q4 2020

Feb 11, 2021
BUY
$47.25 - $65.16 $6.14 Million - $8.47 Million
129,931 Added 21763.99%
130,528 $8.08 Million
Q3 2020

Nov 12, 2020
SELL
$46.35 - $61.69 $6.61 Million - $8.79 Million
-142,508 Reduced 99.58%
597 $33,000
Q2 2020

Jul 31, 2020
SELL
$38.58 - $65.07 $29.2 Million - $49.3 Million
-757,622 Reduced 84.11%
143,105 $8.23 Million
Q1 2020

May 01, 2020
BUY
$32.73 - $50.78 $2.46 Million - $3.82 Million
75,135 Added 9.1%
900,727 $36.2 Million
Q4 2019

Feb 14, 2020
SELL
$6.81 - $39.55 $1.2 Million - $6.96 Million
-176,024 Reduced 17.57%
825,592 $32.7 Million
Q3 2019

Nov 14, 2019
BUY
$6.47 - $8.96 $3.91 Million - $5.42 Million
605,004 Added 152.54%
1,001,616 $6.79 Million
Q2 2019

Aug 14, 2019
BUY
$8.31 - $14.85 $3.25 Million - $5.81 Million
390,976 Added 6937.12%
396,612 $3.69 Million
Q1 2019

May 14, 2019
SELL
$10.01 - $13.89 $103,082 - $143,039
-10,298 Reduced 64.63%
5,636 $78,000
Q4 2018

Feb 14, 2019
BUY
$9.15 - $12.26 $90,072 - $120,687
9,844 Added 161.64%
15,934 $174,000
Q3 2018

Nov 14, 2018
BUY
$10.49 - $13.72 $42,295 - $55,319
4,032 Added 195.92%
6,090 $77,000
Q2 2018

Aug 14, 2018
BUY
$10.62 - $13.98 $8,580 - $11,295
808 Added 64.64%
2,058 $27,000
Q1 2018

May 15, 2018
SELL
$5.9 - $14.99 $5,988 - $15,214
-1,015 Reduced 44.81%
1,250 $17,000
Q4 2017

Feb 14, 2018
BUY
$5.53 - $8.42 $9,102 - $13,859
1,646 Added 265.91%
2,265 $13,000
Q3 2017

Nov 14, 2017
BUY
$6.5 - $10.69 $4,023 - $6,617
619
619 $5,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email